There are 2934 resources available
Proffered Paper – Genitourinary tumours, prostate - Invited Discussant LBA48_PR and LBA49_PR
Presenter: Gert De Meerleer
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Slides
Webcast
Neurological complications of immunotherapy
Presenter: Matthias Preusser
Session: CNS complications and management in systemic cancer patients
Resources:
Slides
Webcast
The value of PD-L1 as a biomarker beyond lung cancers
Presenter: Kevin Harrington
Session: Current markers in immunotherapy
Resources:
Slides
Webcast
Targeting the microenvironment
Presenter: Florent Petitprez
Session: Current markers in immunotherapy
Resources:
Slides
Webcast
Introduction
Presenter: Dirk De Ruysscher
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Nutrition before and during CCRT, including treatment and prevention of anorexia
Presenter: Jann Arends
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Prevention and management of “in-field” toxicities: Oesophagus, nausea and vomiting, lung, skin, heart
Presenter: Fiona McDonald
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Prevention and treatment of fatigue
Presenter: Florian Strasser
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Radiotherapy techniques and chemotherapy adjustments to prevent toxicity in the era of immune therapy
Presenter: Dirk De Ruysscher
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Introduction
Presenter: Dirk Arnold
Session: ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard?
Resources:
Slides
Webcast